SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001551163-20-000035
Filing Date
2020-05-14
Accepted
2020-05-14 14:48:04
Documents
46
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10q.htm 10-Q 513613
2 0001551163-20-000035-3101.htm EX-31 7696
3 0001551163-20-000035-3102.htm EX-31 8170
4 0001551163-20-000035-3201.htm EX-32 4289
  Complete submission text file 0001551163-20-000035.txt   2017471

Data Files

Seq Description Document Type Size
5 sgbi-20200331.xml EX-101.INS 282782
6 sgbi-20200331.xsd EX-101.SCH 19879
7 sgbi-20200331_cal.xml EX-101.CAL 28268
8 sgbi-20200331_def.xml EX-101.DEF 59338
9 sgbi-20200331_lab.xml EX-101.LAB 147078
10 sgbi-20200331_pre.xml EX-101.PRE 129953
Mailing Address 352 SOUTH 200 WEST SUITE 3 FARMINGTON UT 84025
Business Address 352 SOUTH 200 WEST SUITE 3 FARMINGTON UT 84025 011 49 (40) 6093120
SANGUI BIOTECH INTERNATIONAL INC (Filer) CIK: 0001104280 (see all company filings)

IRS No.: 841330732 | State of Incorp.: CO | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 000-29233 | Film No.: 20877108
SIC: 2834 Pharmaceutical Preparations